Emotional Release After Trigger Point Needling to Treat Myofascial Pain of the Head and Neck - Prospective Study
Launched by TEL-AVIV SOURASKY MEDICAL CENTER · Mar 30, 2025
Trial Information
Current as of July 04, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The most common chronic pain of the orofacial region is myofascial pain related to the muscles of mastication and the neck.
Which is classified according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD).
In the DC-TMD, the "Axis I" arm, namely the "physical diagnosis" includes "muscular" disorders as well as "joint" disorders.
The DC/TMD also includes the Axis II - psychosocial arm with comorbidities such as Anxiety, Depression, PTSD.
The cause of myofascial pain is poorly understood - there is no clear organic cause and the modern understanding is that most of the pa...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The study group will include patients which consent to the study and are diagnosed with: Myalgia/Local Myalgia or Myofascial Pain or Myofascial pain with referral or Headache attributed to TMD with or without concurrent diagnosis related to the temporomandibular joint itself.
- Exclusion Criteria:
- Patients who are not eligible for IMS therapy will be excluded:
- • PLT count under 80,000
- • Active or chronic infection at site of pain
- • Known allergy to amide local anesthetics
- • Severe bleeding disorder such as Hemophilia
- • If treated with Warfarin INR over 3
About Tel Aviv Sourasky Medical Center
Tel Aviv Sourasky Medical Center, a leading academic medical institution in Israel, is renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a multidisciplinary approach, the center integrates cutting-edge medical technology and evidence-based practices to enhance patient care and outcomes. Its robust infrastructure supports a diverse range of clinical studies, fostering collaboration among healthcare professionals, researchers, and industry partners. The center's dedication to research excellence and patient safety positions it as a key player in the global clinical research landscape, driving advancements in medical knowledge and treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tel Aviv, , Israel
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported